Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Nguyen, Thanh V ^a,b   Sacci, John B ^c   De La Vega, Patricia ^c,d   John, Chandy C ^e   James, Anthony A ^a,f   Kang, Angray S ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NeoGenomics California   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d US Military Malaria Vaccine Program   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; HEXAHISTIDINE; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE ANTIGEN; MEMBRANE ANTIGEN MB2; POLYCLONAL ANTIBODY; POLYCLONAL ANTISERUM; POLYPEPTIDE; RABBIT ANTISERUM; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; MB2 PROTEIN, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOBLOTTING; KENYA; LIFE CYCLE; MALARIA FALCIPARUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE; PARASITE ISOLATION; PLASMA; PLASMODIUM FALCIPARUM; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; SPOROZOITE; ANIMAL; BLOOD; IMMUNOLOGY; METHODOLOGY;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; KENYA; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SPOROZOITES;

EID: 72449195726     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-235     Document Type: Article

References (39)

1. World Malaria Report 2008. M Aregawi R Cibulskis M Otten R Williams C Dye, WHO Global Malaria Programme Geneva: World Health Organisation, Aregawi M, Cibulskis R, Otten M, Williams R, Dye C, 2008
2. Update on the clinical development of candidate malaria vaccines. WR Ballou M Arevalo-Herrera D Carucci TL Richie G Corradin C Diggs P Druilhe BK Giersing A Saul DG Heppner, et al. Am J Trop Med Hyg 2004 71 2 Suppl 239 247 15331843
3. Malaria vaccines. Evaluation and implementation. B Greenwood, Acta Trop 2005 95 298 304 10.1016/j.actatropica.2005.04.017 15955523
4. Malaria. BM Greenwood K Bojang CJ Whitty GA Targett, Lancet 2005 365 9469 1487 1498 10.1016/S0140-6736(05)66420-3 15850634
5. Malaria vaccine developments. VS Moorthy MF Good AV Hill, Lancet 2004 363 150 156 10.1016/S0140-6736(03)15267-1 14726170
6. Pre-erythrocytic malaria vaccines: towards greater efficacy. AV Hill, Nat Rev Immunol 2006 6 21 32 10.1038/nri1746 16493425
7. Immunization of man against sporozite-induced falciparum malaria. DF Clyde H Most VC McCarthy JP Vanderberg, Am J Med Sci 1973 266 169 177 10.1097/00000441-197309000-00002 4583408
8. Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. KA Bojang PJ Milligan M Pinder L Vigneron A Alloueche KE Kester WR Ballou DJ Conway WH Reece P Gothard, et al. Lancet 2001 358 1927 1934 10.1016/S0140-6736(01)06957-4 11747915
9. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. TC Luke SL Hoffman, J Exp Biol 2003 206 Pt 21 3803 3808 10.1242/jeb.00644 14506215
10. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. JB Dame JL Williams TF McCutchan JL Weber RA Wirtz WT Hockmeyer WL Maloy JD Haynes I Schneider D Roberts, et al. Science 1984 225 4662 593 599 10.1126/science. 6204383 6204383
11. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. N Yoshida RS Nussenzweig P Potocnjak V Nussenzweig M Aikawa, Science 1980 207 71 73 10.1126/science.6985745 6985745
12. Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. F Zavala AH Cochrane EH Nardin RS Nussenzweig V Nussenzweig, J Exp Med 1983 157 1947 1957 10.1084/jem.157.6.1947 6189951
13. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. D Herrington J Davis E Nardin M Beier J Cortese H Eddy G Losonsky M Hollingdale M Sztein M Levine, et al. Am J Trop Med Hyg 1991 45 539 547 1951863
14. IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes. JA Chappel MR Hollingdale AS Kang, Hum Antibodies 2004 13 91 96 15598989
15. Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor. JA Chappel WO Rogers SL Hoffman AS Kang, Malar J 2004 3 28 10.1186/1475-2875-3-28 15283866
16. Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS, S/AS02, in semi-immune adults in The Gambia. M Pinder WH Reece M Plebanski P Akinwunmi KL Flanagan EA Lee T Doherty P Milligan A Jaye N Tornieporth, et al. Clin Exp Immunol 2004 135 286 293 10.1111/j.1365-2249.2004. 02371.x 14738458
17. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. KJ Robson JR Hall MW Jennings TJ Harris K Marsh CI Newbold VE Tate DJ Weatherall, Nature 1988 335 79 82 10.1038/335079a0 3045563
18. Characterization of Plasmodium falciparum sporozoite surface protein 2. WO Rogers A Malik S Mellouk K Nakamura MD Rogers A Szarfman DM Gordon AK Nussler M Aikawa SL Hoffman, Proc Natl Acad Sci USA 1992 89 9176 9180 10.1073/pnas.89.19.9176 1409621
19. Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP. DA Fidock E Bottius K Brahimi II Moelans M Aikawa RN Konings U Certa P Olafsson T Kaidoh A Asavanich, et al. Mol Biochem Parasitol 1994 64 219 232 10.1016/0166-6851(94)00012-3 7935600
20. Stage-dependent localization of a novel gene product of the malaria parasite, Plasmodium falciparum. TV Nguyen H Fujioka AS Kang WO Rogers DA Fidock AA James, J Biol Chem 2001 276 26724 26731 10.1074/jbc.M103375200 11371568
21. The MB2 gene family of Plasmodium species has a unique combination of S1 and GTP-binding domains. LC Romero TV Nguyen B Deville O Ogunjumo AA James, BMC Bioinformatics 2004 5 83 10.1186/1471-2105-5-83 15222903
22. Biased amino acid composition in repeat regions of Plasmodium antigens. F Verra AL Hughes, Mol Biol Evol 1999 16 627 633 10335656
23. Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes. RA Wrightsman BD Dawson DL Fouts JE Manning, J Immunol 1994 153 3148 3154 7522250
24. Bacterial expression and purification of recombinant Plasmodium yoelii circumsporozoite protein. T Stratmann SR Schmid JF Harper AS Kang, Protein Expr Purif 1997 11 72 78 10.1006/prep.1997.0768 9325141
25. Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya. CC John JS Zickafoose PO Sumba CL King JW Kazura, Infect Immun 2003 71 4320 4325 10.1128/IAI.71.8.4320-4325.2003 12874308
26. Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya. CC John PO Sumba JH Ouma BL Nahlen CL King JW Kazura, Infect Immun 2000 68 5198 5204 10.1128/IAI.68.9.5198-5204.2000 10948144
27. Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. S Mellouk N Berbiguier P Druilhe M Sedegah B Galey L Yuan M Leef Y Charoenvit C Paul S Hoffman, et al. Bull World Health Organ 1990 68 Suppl 52 59 2094592
28. Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes. Y Charoenvit V Fallarme WO Rogers JB Sacci Jr M Kaur JC Aguiar LF Yuan G Corradin E Andersen B Wizel, et al. Infect Immun 1997 65 3430 3437 9234808
29. Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. MR Hollingdale EH Nardin S Tharavanij AL Schwartz RS Nussenzweig, J Immunol 1984 132 909 913 6317752
30. In vitro infectivity of irradiated Plasmodium berghei sporozoites to cultured hepatoma cells. CI Sigler P Leland MR Hollingdale, Am J Trop Med Hyg 1984 33 544 547 6089599 (Pubitemid 14053345)
31. Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines. O Silvie JP Semblat JF Franetich L Hannoun W Eling D Mazier, Parasite Immunol 2002 24 221 223 10.1046/j.1365-3024.2002.00450.x 12010486
32. Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review. SI Hay DJ Rogers JF Toomer RW Snow, Trans R Soc Trop Med Hyg 2000 94 113 127 10.1016/S0035-9203(00) 90246-3 10897348
33. Studies of anopheline mosquitoes transmitting malaria in a newly developed highland urban area: a case study of Moi University and its environs. BM Khaemba A Mutani MK Bett, East Afr Med J 1994 71 159 164 7956862
34. The malaria genome sequencing project: complete sequence of Plasmodium falciparum chromosome 2. MJ Gardner H Tettelin DJ Carucci LM Cummings HO Smith CM Fraser JC Venter SL Hoffman, Parassitologia 1999 41 69 75 10697835
35. Attacking the infected hepatocyte. SL Hoffman ED Franke MR Hollingdale P Druilhe, Malaria vaccine Development Washington, DC: American Society for Microbiology, Hoffman SL, 1996 35
36. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. M Aidoo A Lalvani CE Allsopp M Plebanski SJ Meisner P Krausa M Browning S Morris-Jones F Gotch DA Fidock, et al. Lancet 1995 345 1003 1007 10.1016/S0140-6736(95)90754-8 7536870
37. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. M Aidoo A Lalvani SC Gilbert JT Hu P Daubersies N Hurt HC Whittle P Druihle AV Hill, Infect Immun 2000 68 227 232 10.1128/IAI.68.1.227-232.2000 10603392
38. Recombinant vaccinia viruses for the characterization of Plasmodium falciparum -specific cytotoxic T lymphocytes: recognition of processed antigen despite limited re-stimulation efficacy. M Aidoo A Lalvani HC Whittle AV Hill KJ Robson, Int Immunol 1997 9 731 737 10.1093/intimm/9.5.731 9184918
39. Molecular Cloning: A Laboratory Manual. JF Sambrook DW Russell, Cold Spring Harbor Laboartory Press 3 2001